Faus & Moliner has participated in the European Pharmaceutical Law Forum
The European Pharmaceutical Law Forum has taken place this year from 16 to 20 November as a 100% Virtual Conference
The EU Pharmaceutical Law Forum has comprised, as always, the participation of the most relevant professionals in the field of pharmaceutical law from all over Europe, including both internal and external lawyers and other professionals in the regulatory area, with the purpose of sharing knowledge, updates and strategies to design and shape the future of the EU pharmaceutical legal sector.
Once more speakers have discussed very interesting topics, as evidenced in the program of this important event.
Jordi Faus has participated in the Seminar “Market Access for Innovative Therapies“, along with Marieke Jansen (Head Legal Cell and Gene Europe, Novartis), Adela Williams and Alexander Roussanov (partners, Arnold & Porter).
Jordi Faus has also chaired and conducted the conference dedicated to Regulatory Frameworks and the all the sessions His opening remarks can be downloaded from this page https://faus-moliner.com/wp-content/uploads/2020/11/2020-11-18-Initial-remarks-Jordi-Faus.pdf